tweet me
Tweets
EPGL Med ?Announcement Pre-Market (Tuesday 9-4-12) on new device development and direction. Via Twitter.
9-5-12 Q&A for shareholders via Twitter with Corey W. Hunter M.D. "Future of EPGL Med" Time TBA
"I will say this. I have a ton of patients on whom I can use this device." Primary Care Physician, SC
"I'm looking for a better way to do things and would welcome the prospect of actually properly diagnosing and treating patients." Physician
"I have seen another 20 people today so far that I wish I could have used the device on. Looking forward to it." -Pain Physician
Next week, EPGL Medical team to announce next device under development to shareholders.
Eric Lee M.D. M.A. joins EPGL Med team. We are pleased to have him as he is a dynamic doctor on the cutting edge of pain medicine at NYU
MPDD to have upgrade versions starting with 2.0 in 2013 as we improve design functions and software for specific types of physicians.
Receiving dozens of inquiries from physicians around the world at present. If you are a doctor, please seehttp://www.ncbi.nlm.nih.gov/pubmed/20030744
In 2013, MPDD enters the markets for treatment of back pain, neck pain, fibromyalgia, migraine, sports medicine and rehabilitation.
MPDD to offer physicians and Medicare a desperately needed diagnostic tool for superior diagnosis and treatment of chronic muscle pain.
MPDD device to offer a better diagnostic tool to the estimated $90 billion annual back pain treatment market in the United States.
(0)
(0)
